# US 2005/0260682 A1 · Compositions and methods for diagnosing or treating psoriasis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0260682 A1
- Document ID: US20050260682A1
- Status: Published application
- Kind: A1
- Application number: 11/110,977
- Filed: 2005-04-19
- Published: 2005-11-24
- Earliest claimed: 2001-03-29
- Assignees: UCB Celltech
- Inventors: Patrick Charmley; Ryan Smith; Rhodora Argonza-Barrett; Matthew Fitzgibbon; Kai Wang
- Web page: https://patentgrep.com/patent/US20050260682A1

## CPC

- C07K 14/47: from mammals
- A61P 17/06: Antipsoriatics
- C07K 16/18: against material from animals or humans
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C12N 2799/021: for the expression of a heterologous nucleic acid
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides nucleic acid molecules, polypeptides, antibodies and methods for the diagnosis and/or treatment of psoriasis.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

An isolated antibody that binds specifically to a polypeptide consisting of an amino acid sequence that is at least 70% identical to the amino acid sequence set forth in SEQ ID NO:2.

### Claim 18 (depends on 17)

An isolated antibody of claim 17 wherein said antibody binds specifically to a polypeptide consisting of an amino acid sequence that is at least 80% identical to the amino acid sequence set forth in SEQ ID NO:2.

### Claim 19 (depends on 17)

An isolated antibody of claim 17 wherein said antibody binds specifically to a polypeptide consisting of an amino acid sequence that is at least 90% identical to the amino acid sequence set forth in SEQ ID NO:2.

### Claim 20 (depends on 17)

An isolated antibody of claim 17 wherein said antibody binds specifically to a polypeptide consisting of an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NO:2.

### Claim 21 (depends on 17)

An isolated antibody of claim 17 that binds specifically to a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:2.

### Claim 22 (depends on 17)

An isolated antibody of claim 17 wherein said antibody is a polyclonal antibody.

### Claim 23 (depends on 17)

An isolated antibody of claim 17 wherein said antibody is a monoclonal antibody.

### Claim 24 (depends on 17)

An isolated antibody of claim 17 wherein said antibody is a CDR-grafted antibody.

### Claim at position 10

25-65. (canceled)
